Silver Book Fact

Widespread use of telomerase inhibitors could result in a 50% cure rate and a 25% prolongation of life for 50% of eligible patients with solid tumors.

Shekelle P, Ortiz E, Newberry S, Rich M, et al. Identifying Potential Health Care Innovations for the Elderly of the Future: Health and costs of the future elderly. Health Aff. 2005; 24(2). https://www.ncbi.nlm.nih.gov/pubmed/16186152

Reference

Title
Identifying Potential Health Care Innovations for the Elderly of the Future: Health and costs of the future elderly
Publication
Health Aff
Publication Date
2005
Authors
Shekelle P, Ortiz E, Newberry S, Rich M, et al
Volume & Issue
Volume 24, Issue 2
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Widespread use of selective estrogen receptor modulators could result in an approximately 30% decrease in breast cancer.  
  • A one percent reduction in lung, colorectal, breast, leukemia, pancreatic, and brain cancer mortality would reduce productivity costs by $814 million per year.  
  • A modest decrease of 1% in cancer mortality has been estimated to be worth $500 billion in social value.  
  • In the U.S., new cancer drugs have increased life expectancy at birth by 10.7%.